A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Quinine (Quinine Sulfate)

Antimalarial class · 4 generic manufacturers · 4 ANDAs filed at FDA.

First FDA approval2012-09-28
Generic availableYes · 4 mfrs
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one

$418,980 in CY2024 Part D spend4K claims · 2K beneficiaries · 329 plans surveyed

Lowest NADAC
$0.774/unit
3 NDCs benchmarked, lowest of all strengths.
Average NADAC
$0.774
Across all dosage forms in distribution.
Highest NADAC
$0.774
Range is tight.
Plans with PA
279 / 329
Limited PA friction.

Questions a plan sponsor actually asks.

FAQPage schema11 entries indexed · 4 visible
What is Quinine used for?

Quinine is a Antimalarial medication tracked in Medicare Part D.

Is there a generic for Quinine?

Yes. 4 ANDAs filed at FDA, 4 generic manufacturers currently shipping.

How much does my plan pay for Quinine?

Across 329 Part D plans, Quinine averages $0.774/unit (NADAC). Lowest available: $0.774/unit. Highest in distribution: $0.774/unit.

Is Quinine on the FDA shortage list?

No. Quinine is not currently on the FDA Drug Shortage Database.

7 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Same class. Different math.

Antimalarial5 alternatives in D1
01
Atovaquone
Brand: MEPRON
$0.719Lowest NADAC
7Generic mfrs
$60.4MCY24 Part D spend
Compare →
02
Atovaquone Oral Suspension
Brand: ATOVAQUONE
$0.719Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
03
Atovaquone and Proguanil
Brand: MALARONE
$1.29Lowest NADAC
2Generic mfrs
CY24 Part D spend
Compare →
04
Atovaquone and Proguanil Hydrochloride Pediatric
Antimalarial
$1.29Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
05
Chloroquine
Antimalarial
$2.48Lowest NADAC
4Generic mfrs
$591,313CY24 Part D spend
Compare →

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (4 approvals on file) · NADAC unit costs: CMS NADAC weekly file (3 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.